Clinical trial

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients…

NCT00043108 · Fox Chase Cancer Center, Other · Completed

Key facts

NCT number NCT00043108
Title Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Official title Trimodality Protocol for the Treatment of Locally Advanced, Potentially Resectable Non-Small Cell Lung Cancer Targeting
Lead sponsor Fox Chase Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Lung Cancer
Intervention type Drug, Procedure, Radiation
Interventions carboplatin, paclitaxel, conventional surgery, radiation therapy
Enrollment 19
Start date Jul 1, 2002
Primary completion Dec 1, 2016
Completion Feb 1, 2018
First posted May 7, 2003
Last update posted Feb 3, 2022
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies